investigator

related words
xr
endpoint
faropenem
glumetza
echo
insulin
provenge
technosphere
antibiotic
discovering
nda
hemopure
receptive
proquin
predictive
announce
ceplene
viaject
api
biosensor
related documents
1003124--2/26/2010--PHARMACEUTICAL_PRODUCT_DEVELOPMENT_INC
914475--2/4/2009--NEUROCRINE_BIOSCIENCES_INC
1172480--3/4/2008--SANTARUS_INC
1005201--3/9/2010--DEPOMED_INC
1168652--3/11/2008--HIRERIGHT_INC
1026650--3/7/2008--ERESEARCHTECHNOLOGY_INC_/DE/
1088856--3/26/2010--CORCEPT_THERAPEUTICS_INC
1051514--3/12/2008--ELECTRO_OPTICAL_SCIENCES_INC_/NY
1066833--3/31/2008--DOV_PHARMACEUTICAL_INC
1039151--3/16/2010--KENDLE_INTERNATIONAL_INC
1005201--3/12/2008--DEPOMED_INC
1088856--3/31/2008--CORCEPT_THERAPEUTICS_INC
895051--3/13/2009--ENTREMED_INC
1036968--8/30/2007--VAXGEN_INC
1036968--5/31/2007--VAXGEN_INC
1061983--3/12/2009--CYTOKINETICS_INC
1088856--3/31/2009--CORCEPT_THERAPEUTICS_INC
875622--3/31/2009--BIOSPECIFICS_TECHNOLOGIES_CORP
1051514--3/4/2010--ELECTRO_OPTICAL_SCIENCES_INC_/NY
914475--2/11/2008--NEUROCRINE_BIOSCIENCES_INC
related topics
{product, candidate, development}
{property, intellectual, protect}
{financial, litigation, operation}
{regulation, change, law}
{stock, price, share}
{operation, natural, condition}
{personnel, key, retain}
{investment, property, distribution}
{interest, director, officer}
{product, market, service}
{cost, regulation, environmental}
{regulation, government, change}
{loss, insurance, financial}
{loan, real, estate}
{acquisition, growth, future}
{provision, law, control}
{stock, price, operating}
{debt, indebtedness, cash}
{system, service, information}
{product, liability, claim}